摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-chloro-6-ethyl-5-fluoro-4-hydroxypyrimidine ammonium salt | 188416-27-5

中文名称
——
中文别名
——
英文名称
2-chloro-6-ethyl-5-fluoro-4-hydroxypyrimidine ammonium salt
英文别名
ammonia; 2-chloro-6-ethyl-5-fluoro-1H-pyrimidin-4-one;azane;2-chloro-4-ethyl-5-fluoro-1H-pyrimidin-6-one
2-chloro-6-ethyl-5-fluoro-4-hydroxypyrimidine ammonium salt化学式
CAS
188416-27-5
化学式
C6H6ClFN2O*H3N
mdl
——
分子量
193.608
InChiKey
SRHMZIBWCLNYMC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.29
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    42.5
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    2-chloro-6-ethyl-5-fluoro-4-hydroxypyrimidine ammonium salt 在 5%-palladium/activated carbon 、 氢气三乙胺三氯氧磷 作用下, 以 乙醇二氯甲烷 为溶剂, 40.0~50.0 ℃ 、344.75 kPa 条件下, 反应 8.0h, 生成 4-氯-6-乙基-5-氟嘧啶
    参考文献:
    名称:
    Process Development of Voriconazole:  A Novel Broad-Spectrum Triazole Antifungal Agent
    摘要:
    In the synthesis of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (voriconazole), the relative stereochemistry is set in the addition of a 4-(1-metalloethyl)-5-fluoropyrimidine derivative to 1-(2,4-difluorophenyl)-2-(1H-1 ,2,4-triazol-1-yl)-1-ethanone, The diastereo-control of this reaction has been examined by variation of pyrimidine substitution pattern and by changes in the metalation and reaction conditions. Excellent diastereoselection (12: ii is obtained using an organozinc derivative of 6-(1-bromoethyl)-4-chloro-5-fluoropyriminidine. lifter removal cf the chlorine from the pyrimidine ring? the absolute stereochemistry of voriconazole is established via a diastereomeric salt resolution process using (1R)-10 camphorsulfonic acid. Synthetic routes to the pyrimidine partner have also been evaluated. The initial six-step development route from 5-fluorouracil has been superseded by a four-step synthesis involving fluorination of methyl 3-oxopentanoate and cyclisation with formamidine acetate.
    DOI:
    10.1021/op0000879
  • 作为产物:
    参考文献:
    名称:
    Preparation of triazoles by organometallic addition to ketones and intermediates therefor
    摘要:
    该方法用于制备以下化合物:或其酸加合物或碱盐,其中R是苯基,可以选择地被1至3个取代基取代,每个取代基独立地选自卤素和三氟甲基;R1是C1-C6烷基;“Het”是嘧啶基,可以选择地被1至3个取代基取代,每个取代基独立地选自C1-C4烷基、C1-C4烷氧基、卤素、氧代基、苄基和苄氧基,包括将以下化合物与以下化合物反应:其中X是氯、溴或碘,在锌的存在下进行反应;至少使用碘或路易斯酸;和无水有机溶剂:可选择进一步将所得化合物与酸或碱反应,形成相应的酸加合物或碱盐。
    公开号:
    US06586594B1
点击查看最新优质反应信息

文献信息

  • Org. Process Res. Dev.​ 2001, 5, 28-36
    作者:
    DOI:——
    日期:——
  • Process Development of Voriconazole:  A Novel Broad-Spectrum Triazole Antifungal Agent
    作者:Mike Butters、Julie Ebbs、Stuart P. Green、Julie MacRae、Matthew C. Morland、Charles W. Murtiashaw、Alan J. Pettman
    DOI:10.1021/op0000879
    日期:2001.1.1
    In the synthesis of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (voriconazole), the relative stereochemistry is set in the addition of a 4-(1-metalloethyl)-5-fluoropyrimidine derivative to 1-(2,4-difluorophenyl)-2-(1H-1 ,2,4-triazol-1-yl)-1-ethanone, The diastereo-control of this reaction has been examined by variation of pyrimidine substitution pattern and by changes in the metalation and reaction conditions. Excellent diastereoselection (12: ii is obtained using an organozinc derivative of 6-(1-bromoethyl)-4-chloro-5-fluoropyriminidine. lifter removal cf the chlorine from the pyrimidine ring? the absolute stereochemistry of voriconazole is established via a diastereomeric salt resolution process using (1R)-10 camphorsulfonic acid. Synthetic routes to the pyrimidine partner have also been evaluated. The initial six-step development route from 5-fluorouracil has been superseded by a four-step synthesis involving fluorination of methyl 3-oxopentanoate and cyclisation with formamidine acetate.
  • Preparation of triazoles by organometallic addition to ketones and intermediates therefor
    申请人:Pfizer, Inc.
    公开号:US06586594B1
    公开(公告)日:2003-07-01
    A process for the preparation of a compound of the formula: or an acid addition or base salt thereof, wherein R is phenyl optionally substituted by 1 to 3 substituents each independently selected from halo and trifluoromethyl; R1 is C1-C6 alkyl; and “Het” is pyrimidinyl optionally substituted by 1 to 3 substituents each independently selected from C1-C4 alkyl, C1-C4 alkoxy, halo, oxo, benzyl and benzyloxy, comprising reacting a compound of the formula: with a compound of the formula wherein X is chloro, bromo or iodo, the reaction taking place in the presence of zinc; at least one of iodine or a Lewis acid; and an aprotic organic solvent: optionally further reacting the resulting compound with an acid or base to form the corresponding acid addition or base salt thereof.
    该方法用于制备以下化合物:或其酸加合物或碱盐,其中R是苯基,可以选择地被1至3个取代基取代,每个取代基独立地选自卤素和三氟甲基;R1是C1-C6烷基;“Het”是嘧啶基,可以选择地被1至3个取代基取代,每个取代基独立地选自C1-C4烷基、C1-C4烷氧基、卤素、氧代基、苄基和苄氧基,包括将以下化合物与以下化合物反应:其中X是氯、溴或碘,在锌的存在下进行反应;至少使用碘或路易斯酸;和无水有机溶剂:可选择进一步将所得化合物与酸或碱反应,形成相应的酸加合物或碱盐。
查看更多